NASDAQ:DERM Journey Medical Q3 2025 Earnings Report $7.00 -0.21 (-2.91%) Closing price 10/13/2025 04:00 PM EasternExtended Trading$6.98 -0.01 (-0.21%) As of 10/13/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Journey Medical EPS ResultsActual EPSN/AConsensus EPS -$0.05Beat/MissN/AOne Year Ago EPSN/AJourney Medical Revenue ResultsActual RevenueN/AExpected Revenue$18.85 millionBeat/MissN/AYoY Revenue GrowthN/AJourney Medical Announcement DetailsQuarterQ3 2025Date11/11/2025TimeBefore Market OpensConference Call DateTuesday, November 11, 2025Conference Call Time7:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Journey Medical Earnings HeadlinesJourney Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from AnalystsOctober 13 at 3:11 AM | americanbankingnews.comJourney Medical Corporation to Participate in October 2025 Investor ConferencesOctober 8, 2025 | globenewswire.comBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's preparing for a "mind blowing" new launch that could see Tesla move away from electric cars... and into a new market.October 14 at 2:00 AM | Altimetry (Ad)Journey Medical Corp Amends Credit Agreement with SWKSeptember 26, 2025 | tipranks.comSummers Value Partners’ Update on Journey Medical (DERM)September 22, 2025 | insidermonkey.comJourney Medical: EMROSI's Ramp Puts Profitability On The HorizonSeptember 6, 2025 | seekingalpha.comSee More Journey Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Journey Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Journey Medical and other key companies, straight to your email. Email Address About Journey MedicalJourney Medical (NASDAQ:DERM) Corp, headquartered in Fairfield, New Jersey, is a commercial dermatology company focused on acquiring, developing and marketing prescription dermatology products in the United States. Since its incorporation in 2019, the company has built a portfolio of both branded and generic topical therapies designed to address a range of skin conditions, including acne, atopic dermatitis, fungal infections and inflammatory lesions. The company’s product lineup features antibiotic/anti-inflammatory combinations and corticosteroid-based formulations delivered through proprietary gel, cream and foam vehicles. Journey Medical leverages an in-house commercial infrastructure, including a specialized sales force and key partnerships with pharmacies and distributors, to reach dermatology practices and healthcare providers nationwide. Underpinning its growth strategy is an acquisition-driven approach that targets established, off-patent dermatology assets with stable prescription demand. The company’s management team, comprised of executives with deep experience in pharmaceutical marketing and specialty drug launches, continues to screen for complementary assets to expand its addressable market and enhance shareholder value.View Journey Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi Deal Upcoming Earnings ASML (10/15/2025)Kinder Morgan (10/15/2025)Bank of America (10/15/2025)Prologis (10/15/2025)Abbott Laboratories (10/15/2025)Morgan Stanley (10/15/2025)The PNC Financial Services Group (10/15/2025)Progressive (10/15/2025)Interactive Brokers Group (10/16/2025)CSX (10/16/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
